ERBB2 and prostate carcinoma: ERBB2 is expressed at a low level and almost undetectable in normal tissues [37], but it is found to be overexpressed in multiple tumors, such as breast cancer, ovary carcinoma, prostate carcinoma, and non-small-cell lung cancer [38,39,40].